Fatal tetanus in a drug abuser with "protective" antitetanus antibodies

被引:26
作者
Abrahamian, FM
Pollack, CV
LoVecchio, F
Nanda, R
Carlson, RW
机构
[1] Maricopa Integrated Hlth Syst, Dept Emergency Med, Phoenix, AZ USA
[2] Maricopa Integrated Hlth Syst, Dept Internal Med, Phoenix, AZ USA
关键词
tetanus; tetanus toroid antibody; anoxic injury; injecting-drug user;
D O I
10.1016/S0736-4679(99)00192-4
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Tetanus is a rare disease in the United States. From 1995-1997, the average annual incidence of tetanus was 0.15/1,000,000 population. Injecting-drug users, particularly those who use heroin, are among the highest risk population for acquiring tetanus. We present a case of an injecting-drug user who was seen in the emergency department with worsening diffuse midthoracic back pain and spasms. He subsequently developed acute respiratory failure and central nervous system hypoxic injury. Serum obtained before administration of tetanus immune globulin showed a tetanus antibody titer greater than 16 times the level considered protective. Because of limited human data on the minimum protective level of neutralizing antibody, as well as reports of tetanus among individuals with "protective" antibody titers, the diagnosis of tetanus should not be excluded solely on the basis of antitetanus titers. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:189 / 193
页数:5
相关论文
共 12 条
[1]   TREATMENT OF TETANUS - AN OPEN STUDY TO COMPARE THE EFFICACY OF PROCAINE PENICILLIN AND METRONIDAZOLE [J].
AHMADSYAH, I ;
SALIM, A .
BRITISH MEDICAL JOURNAL, 1985, 291 (6496) :648-650
[2]  
[Anonymous], 1998, MMWR-MORBID MORTAL W, V47, P1
[3]   TETANUS DESPITE PREEXISTING ANTI-TETANUS ANTIBODY [J].
BERGER, SA ;
CHERUBIN, CE ;
NELSON, S ;
LEVINE, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1978, 240 (08) :769-770
[4]   TETANUS - PATHOPHYSIOLOGY, MANAGEMENT, AND PROPHYLAXIS [J].
BLECK, TP .
DM DISEASE-A-MONTH, 1991, 37 (09) :551-603
[5]   SEVERE TETANUS IN IMMUNIZED PATIENTS WITH HIGH ANTITETANUS TITERS [J].
CRONE, NE ;
REDER, AT .
NEUROLOGY, 1992, 42 (04) :761-764
[6]   A POPULATION-BASED SEROLOGIC SURVEY OF IMMUNITY TO TETANUS IN THE UNITED-STATES [J].
GERGEN, P ;
MCQUILLAN, GM ;
KIELY, M ;
EZZATIRICE, TM ;
SUTTER, RW ;
VIRELLA, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (12) :761-766
[7]  
GROLEAU G, 1992, Emergency Medicine Clinics of North America, V10, P351
[8]  
IPSEN J, 1961, J IMMUNOL, V86, P50
[9]   CLINICAL TETANUS DESPITE A PROTECTIVE LEVEL OF TOXIN-NEUTRALIZING ANTIBODY [J].
PASSEN, EL ;
ANDERSEN, BR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 255 (09) :1171-1173
[10]  
Pryor T, 1997, J FAM PRACTICE, V44, P299